SEC Form 4 · accession 0001144204-17-018989
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas D Brown
Director
Period of report
Apr 1, 2017
Accepted (ET)
Apr 4, 2017 · 7:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $24.20 | Apr 1, 2017 | A | 11,721 | A | — | Apr 1, 2027 | Common Stock | 11,721 | 11,721 | D |
| Stock Option (right to buy)F2 | $24.20 | Apr 1, 2017 | A | 35,162 | A | — | Apr 1, 2027 | Common Stock | 35,162 | 35,162 | D |
Explanation of responses
- F1The option vests in 12 equal monthly installments, with the first installment vesting on May 1, 2017
- F2The option vests in 5 equal annual installments, with the first installment vesting on April 1, 2018.